Antifungal Prophylaxis and Risk for Invasive Mold Infections in Children with Hematologic Malignancies

被引：0
|
作者：
Ikwuezunma, Ashley
Dutta, Ankhi
Castellanos, Maria Isabel
Paek, Hana
Palazzi, Debra
Rabin, Karen R.
Scheurer, Michael E.
Gramatges, Maria Monica
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-140483
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis
    Lamoth, Frederic
    Chung, Shimin J.
    Damonti, Lauro
    Alexander, Barbara D.
    CLINICAL INFECTIOUS DISEASES, 2017, 64 (11) : 1619 - 1621
  • [42] Risk Factors for Invasive Mold Infections and Implications for Choice of Prophylaxis after Allogeneic Stem Cell Transplantation
    Blennow, Ola
    Remberger, Mats
    Torlen, Johan
    Szakos, Attila
    Ljungman, Per
    Mattsson, Jonas
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (09) : 1684 - 1689
  • [43] Invasive Fungal Infections in Children With Hematologic and Malignant Diseases
    Ozsevik, Sevinc N.
    Sensoy, Gulnar
    Karli, Arzu
    Albayrak, Canan
    Dagdemir, Ayhan
    Belet, Nursen
    Elli, Murat
    Fisgin, Tunc
    Ozyurek, Emel
    Duru, Feride
    Albayrak, Davut
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2015, 37 (02) : E69 - E72
  • [44] Risk factors for invasive aspergillosis in neutropenic patients with hematologic malignancies
    Mühlemann, K
    Wenger, C
    Zenhäusern, R
    Täuber, MG
    LEUKEMIA, 2005, 19 (04) : 545 - 550
  • [45] Risk factors for invasive aspergillosis in neutropenic patients with hematologic malignancies
    K Mühlemann
    C Wenger
    R Zenhäusern
    M G Täuber
    Leukemia, 2005, 19 : 545 - 550
  • [46] Effectiveness of combined proton pump inhibitors and posaconazole prophylaxis against invasive fungal infections in patients with hematologic malignancies: a retrospective study
    Liu, Yan
    Qu, Ruochen
    Zhao, Yan
    Wang, Ziyi
    Yuan, Shizhao
    Liu, Shuai
    Zhou, Chunhua
    Yu, Jing
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2025, 47 (02) : 382 - 391
  • [47] Prospective trial finds nystatin mouthwash effective prophylaxis for pulmonary invasive fungal infections that originate in the throat of patients with hematologic malignancies
    Hu, R.
    Jiang, X.
    Wu, Y.
    NEOPLASMA, 2013, 60 (03) : 315 - 321
  • [48] A clinical approach to assess treatment for presumed and documented invasive mold infections in patients with hematologic malignancies: Focus on Spanish Society of Chemotherapy Guidelines
    Kontoyiannis, Dimitrios P.
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2011, 24 (04) : 173 - 174
  • [49] Empirical antifungal treatment for diagnosed and undiagnosed invasive fungal disease in patients with hematologic malignancies
    Deng, Qi
    Lv, Hai-rong
    Lin, Xue-mei
    Zhao, Ming-feng
    Geng, Li
    Li, Yu-ming
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (07) : 1209 - 1216
  • [50] Impact of testing posaconazole plasma concentrations on epidemiology of antifungal prophylaxis and therapy in patients with hematologic malignancies
    Hoenigl, M.
    Valentin, V.
    Raggam, R. B.
    Valentin, A.
    Woelfler, A.
    Seeber, K.
    Zollner-Schwetz, I.
    Krause, R.
    MYCOSES, 2012, 55 : 96 - 96
12345